Navigation Links
Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Date:10/20/2008

in clinical quantities to support clinical trials; and cysteamine's ability to benefit NASH patients. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may invent better technology; that our products may not work as well as hoped or worse, that our products may harm recipients; and that we may not be able to raise sufficient funds for development or working capital when we require it. As well, our products may never develop into useful products and even if they do, they may not be approved for sale to the public. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in our filings from time to time with the Securities and Exchange Commission (the "SEC"), which we strongly urge you to read and consider, including our Registration Statement on Form S-1 that was declared effective on August 7, 2008; our annual report on Form 10-KSB filed with the SEC on November 14, 2007; and our Form 10-QSB filed with the SEC on July 9, 2008, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Su
'/>"/>
SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Provides Update of Product Programs
4. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Critical Pharmaceuticals Enter Sustained Release hGH Arena
11. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
(Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
(Date:7/22/2014)... 2014 The number of people overdosing from ... day. Twenty-three percent of the workforce has misused prescription ... and Health, making opioid use a serious threat to ... at the correct dosage with a valid prescription, subtle ... National Safety Council released a guide for ...
Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3
... Hospital today announced that revolutionary three-dimensional mammography imaging ... patient appointments at the Evergreen Breast Center, which ... Seattle area to offer the breakthrough screening and ... three-dimensional (3-D) digital imaging to create a complete ...
... Prescription drug spending growth slowed from an estimated ... according to new data released today by the Centers ... in Health Affairs. Researchers credit the slowdown in spending ... shifting medication use toward lower cost generic drugs. ...
Cached Medicine Technology:Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 2Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 3PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth 2
(Date:7/22/2014)... City, OK (PRWEB) July 22, 2014 ... the launch of the newest component of its existing ... area hospital within the regional SSM Health Care of ... affiliate health centers that shares its services with an ... primary care centers across several states. As a forward-thinking ...
(Date:7/22/2014)... Provectus has started leading projects ... in addition to working with the long known OS ... as well as the creation of services for other ... requires special gadgets for work, leisure and business. Since ... healthcare, logistics, travelling, sports, education, science and other verticals. ...
(Date:7/22/2014)... 2014 It all started as a meeting ... find common ground. Willem de Liefde wanted to help family, ... lives or careers. , Willem wrote The Ego’s Echo for ... the surface of things. It is an invitation to go ... and commitment. , This book represents a breakthrough in the ...
(Date:7/22/2014)... The market for beauty products in the ... according to new industry reports. Women who seek out ... a new guide published at the Cherry News website. ... at http://cherrynews.com/best-nourishing-eye-serum . , This published guide is ... of the top skin improvement products on the market. ...
(Date:7/22/2014)... 2014 Mona Khan Company today announced ... 15th & 16th, 2014, at the Blanks Studio in ... nationally accredited Bollywood workout was launched in the San ... appealing Bollywood culture, Bombay Jam® is a dance-based total ... and designed with authentic Bollywood flavor. Instructor trainings have ...
Breaking Medicine News(10 mins):Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 3Health News:Provectus Announces Development for Google Glass and Wearables 2Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3
... introduces Senator Daschle at his confirmation hearing to be ... WASHINGTON, Jan. 8 Bipartisan Policy Center (BPC) founding ... Health and Human Services Secretary, was introduced by fellow ... confirmation hearing today. The hearing was convened by the ...
... to condemn hurtful comments, study suggests , , THURSDAY, Jan. ... would react to racist acts, a new Canadian study says. ... in Toronto, still chose to partner for an experiment with ... their white peer made racist comments about the black person ...
... for Camp Courage at Mall of AmericaMINNEAPOLIS, Jan. 8 , WHO: ... off their talent in the 3rd annual Dance, ... event will be emceed by Tom ... Participants raise money through pledges to benefit Camp, ...
... in 2009 Continues Growth TrendNORTH HOLLYWOOD, Calif., Jan. 8 ... IPCM ), a leading national hospitalist physician group practice ... practice of Midwest Acute Care Consultants, Inc. (MACC) in ... the St. Louis market, where IPC has established a ...
... The Pew Charitable Trusts announced today that Erik ... safety programs, in its Health & Human Services Policy ... general counsel of the Senate Committee on Environment and ... environmental policy and consumer advocacy to Pew. "We are ...
... Cephalon, Inc . (Nasdaq: CEPH ) ... will present at the J.P. Morgan Healthcare Conference, to ... at approximately 4:00 p.m. Pacific Time (7 p.m. Eastern Time). ... section of the company,s website. The webcast will be archived ...
Cached Medicine News:Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Many Turn Blind Eye to Racism 2Health News:Dance With Courage to Benefit Camp Courage 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
... reading card was designed by James Lebensohn, ... near point exercises including words, numbers and ... 20/200, 20/100, 20/65, 20/50, 20/40, 20/30, 20/25, ... in English and metric, Jaeger, point size ...
Standard reading test. Music Bars and Tables...
... The PowerLab 4/25 is an ... suitable for teaching and research use ... animal physiology, pharmacology, neurophysiology, biology, zoology, ... 4/25 supports all ADInstruments signal conditioners ...
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
Medicine Products: